If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Medical Science Liaison
Download FREE Excerpt
19 Info Graphics
15 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
The role of Medical Science Liaisons (MSL) has continued to steadily grow within the healthcare industry. Consequently, Medical Affairs leaders must now, more than ever, re-assess their MSL management practices to be successful in this competitive environment. The study captures critical insights regarding MSL team performance measurement, budget allocations and challenges/lessons learned.
This research presents 2014 data versus data from 2011, and examines the growing roles and responsibilities of Medical Science Liaisons within leading healthcare organizations. Medical Affairs leaders can use this study as a benchmark for future strategic and resource planning and best-practice implementation for the medical science liaison function.
Pharmaceutical; Biotech; Manufacturing; Medical Device; Consumer Products; Diagnostic; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories
Abbvie; AstraZeneca Pharmaceuticals; Biogen; BARD; Baxter International; Bayer Healthcare; Covidien; Genentech; Gilead Sciences; Kadmon Pharmaceuticals; Medtronic; Sanofi; Shire; ViiV Healthcare; Jazz Pharmaceuticals